Juraj Bodo

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma”.

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

Cancer Research(2020)10.1158/0008-5472.can-19-1077

N/A

0.546DataRank · unranked

37 citations

Huimin Liu, Chuanfeng Fang, Chen Li, Fjorela Xhyliu, Hayley Dysert +16 more

Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance

Cell Death and Disease(2020)10.1038/s41419-020-03144-y

N/A

0DataRank · unranked

258 citations

Juraj Bodo, Brian T. Hill, Eric D. Hsi, Alexandru Almasan, Isha Kapoor

Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies

Cell Death and Disease(2021)10.1038/s41419-021-04353-9

N/A

0DataRank · unranked

18 citations

Juraj Bodo, Brian T. Hill, Alexandru Almasan, Isha Kapoor

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Leukemia(2025)10.1038/s41375-024-02429-x

N/A

0DataRank · unranked

4 citations

Carmelo Gurnari, Carlos Bravo‐Pérez, Arda Durmaz, Nakisha D Williams, Hussein Awada +13 more